Cluster-randomized controlled trial examined decompression with and without duraplasty ...
Procept BioRobotics anticipates sharing the primary endpoint results from WATER IV in 2027.
New results from the Phase 3 SUNRISE clinical trial show that tezepelumab significantly reduced the need for long-term oral ...